- Nearly one in five people with diabetes are regularly unable to attend a full day at work due to ...
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...
-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended ...
- Broadens later stage capabilities and Increases Asian ...
Doctors know that diabetics have a higher than normal risk of dying of heart attacks or strokes, but new research on ...